Join
Live feed
·
INSIDERFilingvia Quantisnow
Enliven Therapeutics Inc. logo

CHIEF MEDICAL OFFICER Collins Helen Louise was granted 25,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELVN· Enliven Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELVN (Enliven Therapeutics Inc.) and more on Quantisnow.